Cervicovaginal and Rectal Fluid as a Surrogate Marker of Antiretroviral Tissue Concentration: Implications for Clinical Trial DesignMackenzie L. Cottrell, Angela D. M. Kashuba, Michael G. Hudgens et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2016Cited by 22
Cervicovaginal and Rectal Fluid as a Surrogate Marker of Antiretroviral Tissue Concentration: Implications for Clinical Trial DesignNicholas J. Shaheen, Michael G. Hudgens, Stephanie A. Malone et al.|UNC Libraries|2020Cited by 0